| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.08 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.07 | 0.08 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |